Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-03-02 Sale | 2026-03-02 6:28 pm | Contineum Therapeutics Inc. | CTNM | Watkins Tim CMO & Head of Development | 3,611 | $15.02 | $54,220 | 249,167 (Direct) | View |
| 2026-01-28 Sale | 2026-01-30 4:52 pm | Contineum Therapeutics Inc. | CTNM | Watkins Tim CMO & Head of Development | 3,611 | $14.18 | $51,188 | 412,778 (Direct) | View |
| 2025-12-29 Sale | 2025-12-30 4:12 pm | Contineum Therapeutics Inc. | CTNM | Watkins Tim CMO & Head of Development | 3,611 | $12.06 | $43,558 | 256,389 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-03-02 Exercise | 2026-03-02 6:28 pm | N/A 2035-04-27 | Contineum Therapeutics Inc. | CTNM | Watkins Tim CMO & Head of Development | 3,611 | $0 | 249,167 (Direct) | View |
| 2026-03-02 Exercise | 2026-03-02 6:28 pm | N/A N/A | Contineum Therapeutics Inc. | CTNM | Watkins Tim CMO & Head of Development | 3,611 | $4.5 | 249,167 (Direct) | View |
| 2026-01-28 Exercise | 2026-01-30 4:52 pm | N/A 2035-04-27 | Contineum Therapeutics Inc. | CTNM | Watkins Tim CMO & Head of Development | 3,611 | $0 | 412,778 (Direct) | View |
| 2026-01-30 Option Award | 2026-01-30 4:52 pm | N/A 2036-01-29 | Contineum Therapeutics Inc. | CTNM | Watkins Tim CMO & Head of Development | 160,000 | $0 | 412,778 (Direct) | View |
| 2026-01-28 Exercise | 2026-01-30 4:52 pm | N/A N/A | Contineum Therapeutics Inc. | CTNM | Watkins Tim CMO & Head of Development | 3,611 | $4.5 | 412,778 (Direct) | View |
| 2025-12-29 Exercise | 2025-12-30 4:12 pm | N/A 2035-04-27 | Contineum Therapeutics Inc. | CTNM | Watkins Tim CMO & Head of Development | 3,611 | $0 | 256,389 (Direct) | View |
| 2025-12-29 Exercise | 2025-12-30 4:12 pm | N/A N/A | Contineum Therapeutics Inc. | CTNM | Watkins Tim CMO & Head of Development | 3,611 | $4.5 | 256,389 (Direct) | View |
| 2025-04-28 Option Award | 2025-04-28 4:21 pm | N/A 2035-04-27 | Contineum Therapeutics Inc. | CTNM | Watkins Tim CMO & Head of Development | 286,000 | $0 | 286,000 (Direct) | View |